Evolus (EOLS) Net Equity Issued and Repurchased (2018 - 2024)
Evolus' (EOLS) quarterly Net Equity Issued and Repurchased came in at $4.2 million in Q2 2024, down 91.05% on a QoQ basis from $47.0 million in Q1 2024.
Evolus (EOLS) Net Equity Issued and Repurchased (2018 - 2024) Analysis & Trends
Evolus (EOLS) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $4.2 million in Q2 2024.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $4.2 million in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $4.2 million (down 91.05% YoY) and the FY2024 annual result came in at $51.2 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased declined to $4.2 million in Q2 2024, from $47.0 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $81.5 million in Q4 2021 to a low of $11000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4.21 Mn |
| Jun 30, 2024 | 4.21 Mn |
| Mar 31, 2024 | 47.00 Mn |
| Mar 31, 2024 | 47.00 Mn |
| Dec 31, 2021 | 81.52 Mn |
| Dec 31, 2021 | 81.52 Mn |
| Sep 30, 2021 | 8.95 Mn |
| Sep 30, 2021 | 8.95 Mn |
| Jun 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 1.95 Mn |
| Mar 31, 2021 | 11,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Dec 31, 2019 | 72.21 Mn |
| Dec 31, 2019 | 72.21 Mn |
| Sep 30, 2019 | 314,000.00 |
| Sep 30, 2019 | 314,000.00 |
| Jun 30, 2019 | 795,000.00 |
| Jun 30, 2019 | 795,000.00 |
| Dec 31, 2018 | 11.35 Mn |
| Dec 31, 2018 | 11.35 Mn |